ERT (Nasdaq: ERES) announced today that it will release its results for the third quarter 2010 on
Thursday, November 4, 2010
, after the market closes. After the release, the Company will host a conference call at
5:00 PM EDT
For the conference call, interested participants should dial 1-800-860-2442 when calling within
the United States
or 1-412-858-4600 when calling internationally. There will be a playback available as well. To listen to the playback, please call 1-877-344-7529 when calling within
the United States
or 1-412-317-0088 when calling internationally. Conference code for playback is 445264.
This call is being webcast by MultiVu and can be accessed at ERT's website at
. The webcast may also be accessed via the direct link at
. The webcast can be accessed for up to one year on either site.
, eResearchTechnology, Inc. (
) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. It is also a leading provider of centralized respiratory technology and services to evaluate pulmonary function efficacy and safety in clinical development. Sponsors can further use the Company's solutions to streamline the clinical trials process by automating the collection, analysis, and distribution of ePRO clinical data using multi-mode technology in all phases of clinical development as well as selected medical devices for the clinical trials and healthcare industries.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.